SEC FORM
3
SEC Form 3
FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0104 |
Estimated average burden |
hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 06/06/2019
|
3. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc.
[ LDOS ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
X |
Officer (give title below) |
|
Other (specify below) |
SVP and Corporate Comptroller |
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Beneficially Owned |
1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Common Stock |
2,167
|
D |
|
Common Stock |
21,640.6254
|
I |
By Key Executive Stock Deferral Plan |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Stock Option (Right to Buy) |
04/04/2015 |
04/03/2021 |
Common Stock |
3,382
|
27.233 |
D |
|
Stock Option (Right to Buy) |
04/10/2016 |
04/09/2022 |
Common Stock |
6,056
|
31.5489 |
D |
|
Stock Option (Right to Buy) |
03/04/2017 |
03/03/2023 |
Common Stock |
4,266
|
33.8177 |
D |
|
Stock Option (Right to Buy) |
03/03/2018 |
03/02/2024 |
Common Stock |
2,774
|
53.54 |
D |
|
Stock Option (Right to Buy) |
03/08/2020 |
03/07/2026 |
Common Stock |
3,333
|
62.43 |
D |
|
Stock Option (Right to Buy) |
03/02/2019 |
03/01/2025 |
Common Stock |
2,419
|
63.76 |
D |
|
Explanation of Responses: |
Remarks: |
|
/s/ Raymond L. Veldman, Attorney-in-Fact |
06/17/2019 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
POWER OF ATTORNEY
The undersigned hereby constitutes and appoints each of Raymond L.
Veldman, Lafayette Atkinson Jr. and Ramune M. Kligys signing singly,
as the undersigned's true and lawful attorney-in-fact to:
(1) prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and
Exchange Commission (the "SEC") a Form ID, including
amendments thereto, and any other documents necessary or
appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of
reports required by Section 16(a) of the Securities Exchange
Act of 1934 or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the
undersigned's capacity as an executive officer and/or director
of Leidos Holdings, Inc. (the "CompanV'), Forms 3, 4 and 5 in
accordance with Section 16(a) of the Securities and Exchange
Act of 1934 and the rules thereunder, as the same may be
amended from time to time;
(3) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to
complete the execution of any such Form 3, 4 or 5 and the
timely filing of such Form with the SEC and any other
authority; and
(4) take any other action of any type whatsoever with the
foregoing which, in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required by,
the undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as
such attorney-in-fact may approve in his or her discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform each and every act and
thing whatsoever requisite, necessary and proper to be done in
the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such
attorney-in-fact, or his or her substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorney-in-fact,
in serving in such capacity at the request of the undersigned, are
not assuming any of the undersigned's responsibilities to comply
with Section 16 of the Securities and Exchange Act of 1934 and the
rules thereunder, as the same may be amended from time to time.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with
respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing to the foregoing attorneys-in-fact.